SQI Buying Microarray Firm Scienion for $15.6M, and Stock

The proposed purchase is anticipated to further push SQI's entry into the market for technologies for multiplexed protein, antibody, antigen, and molecular microarrays.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.